Testing a Resilience Intervention for Individuals Aging With Multiple Sclerosis (MS)

This study aims to test the efficacy of the EverydayMatters Multiple Sclerosis (MS) program for individuals age 45 or older living with multiple sclerosis. The program involves a 6-week telephone-delivered program to promote resilience and happiness for individuals living with MS.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Nervous System Diseases

Age range

45 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

45 years of age
Diagnosis of multiple sclerosis
regular access to the phone and internet
willing to join a moderated group on MSConnection.org

Exclusion criteria

under 45 years of age
no diagnosis of multiple sclerosis
no access to the phone or internet
unwilling to join moderated group on MSConnection

Treatment and study plan

EverydayMatters

Behavioral

Primary outcomes

Change in Resilience using Connor Davidson Resilience Scale (brief)

Time frame: 6 weeks

10-item self-report measure of resilience.

Secondary outcomes

Change in positive affect and well being using the Quality of Life in Neurological Disorders (NeuroQoL) Positive Affect and Well-Being Short Form

Time frame: 6 weeks

9-item self report measure
Change in Patient Reported Outcomes Measurement Information System (PROMIS) Satisfaction with Social Roles Short Form

Time frame: 6 weeks

4-item self-reported measure of satisfaction with participation in social roles and activities
Change in disease-management self-efficacy using the University of Washington Self-Efficacy Scale

Time frame: 6 weeks

6-item self-report measure of self-efficacy for disability management

Sponsors and collaborators

Lead sponsor

University of Washington

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2016
First posted: Jun 6, 2017
Registry last updated: Jun 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed